Champions Oncology (CSBR) Other Non-Current Liabilities (2011 - 2026)

Champions Oncology's Other Non-Current Liabilities history runs 16 years deep, the most recent figure standing at $27000.0 for Q1 2026.

• In Q1 2026, Other Non-Current Liabilities fell 90.53% year-over-year to $27000.0; the TTM figure through Jan 2026 stood at $27000.0 (down 90.53% YoY), while the FY2025 annual figure was $85000.0, down 78.8% from the prior year.
• Other Non-Current Liabilities was $27000.0 for Q1 2026 at Champions Oncology, down from $46000.0 in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $660000.0 in Q3 2022 to a low of $27000.0 in Q1 2026.
• Historically, Other Non-Current Liabilities has averaged $357117.6 across 5 years, with a median of $391000.0 in 2022.
• The sharpest annual moves came in 2022 and 2026: Other Non-Current Liabilities surged 172.73% in 2022, then slumped 90.53% in 2026.
• A 5-year view of Other Non-Current Liabilities shows it stood at $624000.0 in 2022, then fell by 23.72% to $476000.0 in 2023, then plunged by 31.93% to $324000.0 in 2024, then plunged by 85.8% to $46000.0 in 2025, then slumped by 41.3% to $27000.0 in 2026.
• The last three Other Non-Current Liabilities figures came in at $27000.0 (Q1 2026), $46000.0 (Q4 2025), and $66000.0 (Q3 2025), per Business Quant data.